ReNAgade Emerges With $300m To Pursue Extra-Hepatic Delivery Of RNA Medicines

New CEO Amit Munshi Last Helmed Arena

 
• By Mandy Jackson
  
Notepad with "venture capital" written on it
ReNAgade's series A is one of the largest VC rounds so far in 2023 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business